Allergy

Links between allergic rhinitis and asthma still reinforced
pp. 251-254(4)
Authors: Demoly, P.; Bousquet, P. J.

Impact of allergic rhinitis on asthma: effects on spirometric parameters
pp. 255-260(6)
Authors: Ciprandi, G.; Cirillo, I.; Pistorio, A.

Sinonasal pathology in nonallergic asthma and COPD: `united airway disease' beyond the scope of allergy
pp. 261-267(7)
Authors: Hens, G.; Vanaudenaerde, B. M.; Bullens, D. M. A.; Piessens, M.; Decramer, M.; Dupont, L. J.; Ceuppens, J. L.; Hellings, P. W.

Evaluation of cytokine mRNA in induced sputum from patients with allergic rhinitis: relationship to airway hyperresponsiveness
pp. 268-273(6)
Authors: Sohn, S.-W.; Lee, H.-S.; Park, H.-W.; Chang, Y.-S.; Kim, Y.-K.; Cho, S.-H.; Kim, Y.-Y.; Min, K.-U.

Infections presenting for clinical care in early life and later risk of hay fever in two UK birth cohorts
pp. 274-283(10)
Authors: Bremner, S. A.; Carey, I. M.; DeWilde, S.; Richards, N.; Maier, W. C.; Hilton, S. R.; Strachan, D. P.; Cook, D. G.

Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires
pp. 284-291(8)
Authors: Petersen, K. D.; Kronborg, C.; Gyrd-Hansen, D.; Dahl, R.; Larsen, J. N.; Løwenstein, H.

Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study
pp. 292-298(7)
Authors: Magnan, A.; Meunier, J. P.; Saugnac, C.; Gasteau, J.; Neukirch, F.

From allergen genes to new forms of allergy diagnosis and treatment
pp. 299-309(11)
Author: Vrtala, S.

The CREATE Project: development of certified reference materials for allergenic products and validation of methods for their quantification
pp. 310-326(17)
Authors: van Ree, R.; Chapman, M. D.; Ferreira, F.; Vieths, S.; Bryan, D.; Cromwell, O.; Villalba, M.; Durham, S. R.; Becker, W. M.; Aalbers, M.; André, C.; Barber, D.; Bahima, A. Cistero; Custovic, A.; Didierlaurent, A.; Dolman, C.; Dorpema, J. W.; Felice, G. Di; Eberhardt, F.; Caldas, E. Fernandez; Rivas, M. Fernandez; Fiebig, H.; Focke, M.; Fötisch, K.; Gadermaier, G.; Das, R. G.; Mancebo, E. Gonzalez; Himly, M.; Kinaciyan, T.; Knulst, A. C.; Kroon, A. M.; Lepp, U.; Marco, F. M.; Mari, A.; Moingeon, P.; Monsalve, R.; Neubauer, A.; Notten, S.; Ooievaar-de Heer, P.; Pauli, G.; Pini, C.; Purohit, A.; Quiralte, J.; Rak, S.; Raulf-Heimsoth, M.; Moncin, M. M. San Miguel; Simpson, B.; Tsay, A.; Vailes, L.; Wallner, M.; Weber, B.

SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma
pp. 327-332(6)
Authors: Lei, Z.; Liu, G.; Huang, Q.; Lv, M.; Zu, R.; Zhang, G.-M.; Feng, Z.-H.; Huang, B.

TRAIL mediated signaling in human mast cells: the influence of IgE-dependent activation
pp. 333-340(8)
Authors: Berent-Maoz, B.; Salemi, S.; Mankuta, D.; Simon, H.-U.; Levi-Schaffer, F.

Assessing skin prick tests reliability in ECRHS-I
pp. 341-346(6)
Authors: Bousquet, P.-J.; Chatzi, L.; Jarvis, D.; Burney, P.

Effect of short-term exposure to air pollution and pollen on medical emergency calls: a case-crossover study in Spain
pp. 347-353(7)
Authors: Carracedo-Martinez, E.; Sanchez, C.; Taracido, M.; Saez, M.; Jato, V.; Figueiras, A.

Prevalence and cumulative incidence of food hypersensitivity in the first 3 years of life
pp. 354-359(6)
Authors: Venter, C.; Pereira, B.; Voigt, K.; Grundy, J.; Clayton, C. B.; Higgins, B.; Arshad, S. H.; Dean, T.

The economic costs of severe anaphylaxis in France: an inquiry carried out by the Allergy Vigilance Network
pp. 360-365(6)
Authors: Flabbee, J.; Petit, N.; Jay, N.; Guénard, L.; Codreanu, F.; Mazeyrat, R.; Kanny, G.; Moneret-Vautrin, D. A.

Analysis of CD4+ T-cell gene expression in allergic subjects using two different microarray platforms
pp. 366-369(4)
Authors: Hansel, N. N.; Cheadle, C.; Diette, G. B.; Wright, J.; Thompson, K. M.; Barnes, K. C.; Georas, S. N.

Lupin allergy in peanut-allergic children and teenagers
pp. 370-373(4)
Authors: Shaw, J.; Roberts, G.; Grimshaw, K.; White, S.; Hourihane, J.

Anaphylactic shock because of sublingual immunotherapy overdose during third year of maintenance dose
pp. 374-374(1)
Author: Blazowski, L.

The safety of sublingual immunotherapy with one or more allergens in adults
pp. 375-376(2)
Authors: Lombardi, C.; Gargioni, S.; Cottini, M.; Canonica, G. W.; Passalacqua, G.

High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis
pp. 376-378(3)
Author: Kontou-Fili, K.

A variant of idiopathic angioedema presenting as persistent facial swelling over 1 year
pp. 378-379(2)
Authors: Kim, K. M.; Park, C. S.; Kim, T.-B.; Cho, Y. S.; Moon, H.-B.

Is house dust mite monosensitization associated with clinical disease?
pp. 379-381(3)
Authors: von Hertzen, L. C.; Laatikainen, T.; Pennanen, S.; Mäkelä, M. J.; Haahtela, T.

Corrigendum
pp. 382-382(1)